The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Biomarkers in Transplantation

Genome BC and PROOF Launch Phase Two of Biomarkers in Transplantation

RecycleMeGenome British Columbia and the Prevention of Organ Failure (PROOF) Centre of Excellence at UBC announced the launch of the second phase of the “Biomarkers in Transplantation” project, which aims to use a simple blood test to identify patients who are rejecting a transplanted organ.

The current test for rejection is a biopsy — which costs somewhere between $5-10 thousand dollars — and the average heart transplant recipient will need between 14 and 16 biopsies in the first year alone.

The new test is a biomarker test that has been “validated … in one group of patients” and is now being readied for the Health Canada and FDA approval process.

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 129 other followers